• Explore /
  • Poster
  • / Safety and efficacy of durvalumab in combination with tremelimumab, durvalumab monotherapy, and tremelimumab monotherapy in patients with advanced gastric cancer.

Safety and efficacy of durvalumab in combination with tremelimumab, durvalumab monotherapy, and tremelimumab monotherapy in patients with advanced gastric cancer.

Abstract Poster

Authors

Ronan Kelly

Ronan Joseph Kelly

Johns Hopkins Medicine, Baltimore, MD

Ronan Joseph Kelly , Jeeyun Lee , Yung-Jue Bang , Khaldoun Almhanna , Mariela A. Blum Murphy , Daniel V.T. Catenacci , Hyun Cheol Chung , Zev A. Wainberg , Michael Gibson , Keun Wook Lee , Johanna C. Bendell , Crystal S. Denlinger , Philip Z. Brohawn , Peng He , Jennifer McDevitt , Judson Englert , Geoffrey Yuyat Ku

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Esophageal or Gastric Cancer

Clinical Trial Registration Number

NCT02340975

Citation

J Clin Oncol 36, 2018 (suppl; abstr 4031)

DOI

10.1200/JCO.2018.36.15_suppl.4031

Abstract #

4031

Poster Bd #

220

Abstract Disclosures

Similar Posters

First Author: David Tougeron

First Author: Eileen Mary O'Reilly

First Author: Sadahisa Ogasawara

First Author: Tae-Yong Kim